Abstract:AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA 4666 Recent papers suggest that tumor cells from different cancer types have different profiles of chemokine receptor expression, might respond to chemokine gradients and contribute to metastatic spread. Oligonucleotide microarray results showed a significantly increased expression of CX3CR1 in Clear cell renal cell carcinoma (CCRCC) relative to normal kidney tissue, and promoted us to investigate whether fractalkine-CX3CR1 axis was involved in cell migration and distant metastasis in human CCRCC. The expression level and localization of CX3CR1 in human CCRCC cell lines 786-O, A-498, Caki-1, SN12C and human embryonic kidney cell line HEK293T was realized by western-blotting and immunofluorescence. Wound healing assay and chemotaxis assay were performed to assess cellular migratory ability induced by fractalkine. To assess the signaling pathways involved, cells were incubated with 50nM fractalkine for different time periods, and then, the phosphorylation of p44/p42 MAPK and Akt were tested by western-blotting method. Fractalkine induced cellular migration was done after the cells were treated with the neutralizing antibody to CX3CR1, GPCR (G-protein couple receptor) inhibitor pertussis toxin (PTX), and the blockade of MEK UO126, respectively. Finally, both the expression of CX3CR1 and fractalkine were evaluated using immunohistochemical analysis on tissue microarray (TMA) composed of 78 primary CCRCC individual samples, 16 nonmalignant kidney cortex tissue samples and 16 metastatic lesions of CCRCC. Western blotting showed the expression of CX3CR1 protein in 4 tested cell lines was superior to that in 293T cells. Wound healing assay suggested that fractalkine enhanced the migratory activity in the cells present with membranous CX3CR1. The directed migration activity of cancer cells was induced by fractalkine in a dose-dependent manner. Extracellular signal-related kinases (ERK1 and ERK2) were activated under soluble fractalkine stimulation, whereas the neutralizing antibody of CX3CR1, PTX, and UO126 prevented fractalkine-mediated cellular migration. Statistical analysis of TMA results revealed a significant correlation of high level of CX3CR1 membranous expression with metastasis status (P<0.005) and shorten survival outcomes (P<0.01). A higher percentage of CX3CR1 expression was displayed among the 16 samples from different metastatic sites (62.5%), especially in those came from lung (2/3), bone (5/6) and brain (2/2). In this present study, for the first time, we show that CX3CR1 expressed on cellular membrane of human CCRCC is associated with cellular migration, metastasis and poor prognosis.

Fractalkine/CX3CL1 in Neoplastic Processes

CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis

The Clinical Significance and Involvement in Molecular Cancer Processes of Chemokine CXCL1 in Selected Tumors

The Role of CXCR3 and Its Ligands in Cancer

CX3CR1 Expression Associated with Cellular Migration, Metastasis, and Prognosis in Human Clear Cell Renal Cell Carcinoma

The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers

Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive Cancers: Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer and Prostate Cancer

The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders

Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF-κB cascade in pancreatic cancer cells.

CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer

Chemoattraction, Adhesion and Activation of Natural Killer Cells Are Involved in the Antitumor Immune Response Induced by Fractalkine/cx3cl1.

CXCL3: A key player in tumor microenvironment and inflammatory diseases

Regulation and biological functions of the CX3CL1-CX3CR1 axis and its relevance in solid cancer: A mini-review

The Importance of CXCL1 in Physiology and Noncancerous Diseases of Bone, Bone Marrow, Muscle and the Nervous System

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

Potential Roles and Targeted Therapy of the CXCLs/CXCR2 Axis in Cancer and Inflammatory Diseases

The Role of CXCL11 and its Receptors in Cancer: Prospective but Challenging Clinical Targets

Regulative Role of the CXCL13-CXCR5 Axis in the Tumor Microenvironment

The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment

The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal Organs

Cancer and the chemokine network